We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,347 hedge funds and large institutions have $86.9B invested in Thermo Fisher Scientific in 2018 Q3 according to their latest regulatory filings, with 94 funds opening new positions, 441 increasing their positions, 568 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 63

19% more funds holding in top 10

Funds holding in top 10: 99 → 118 (+19)

2% more funds holding

Funds holding: 1,320 → 1,347 (+27)

3% more capital inflows, than outflows

Capital inflows: $3.89B | Capital outflows: $3.78B

0.75% more ownership

Funds ownership: 87.52% → 88.27% (+0.75%)

9% less call options, than puts

Call options by funds: $282M | Put options by funds: $310M

22% less repeat investments, than reductions

Existing positions increased: 441 | Existing positions reduced: 568

Holders
1,347
Holders Change
+27
Holders Change %
+2.05%
% of All Funds
30.68%
Holding in Top 10
118
Holding in Top 10 Change
+19
Holding in Top 10 Change %
+19.19%
% of All Funds
2.69%
New
94
Increased
441
Reduced
568
Closed
63
Calls
$282​M
Puts
$310​M
Net Calls
-⁠$27.7​M
Net Calls Change
+$3.15​M

TMO Hedge Fund Activity: Q3 2018 in Review

1,347 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2018, worth a combined $86.9B — up 19% from $72.9B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new TMO positions and 63 closed out — a net gain of 31 holders — while 441 added to existing stakes and 568 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $588M. The largest seller was Capital Research Global Investors, cutting an estimated $626M.

  • 1,347 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2018, up from 1,320 in Q2 2018.
  • Funds reported $86.9B of Thermo Fisher Scientific stock for Q3 2018, up 19% quarter-over-quarter.
  • 94 funds opened new Thermo Fisher Scientific positions in Q3 2018 and 63 closed out, a net change of +31 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2018 was T. Rowe Price Associates, an estimated $588M added.
  • The largest Thermo Fisher Scientific seller in Q3 2018 was Capital Research Global Investors, an estimated $626M sold.

Based on aggregated 13F filings for Q3 2018.